|
Market Closed -
Bombay S.E.
18:02:26 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 177.75 INR | -3.84% |
|
+8.78% | +116.11% |
| Market Cap | 52.17B 549M 492M 453M 410M 767M 781M 5.4B 2.17B 27.45B 2.06B 2.02B 86.55B | P/E 2027 * |
23.7x | P/E 2028 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 52.17B 549M 492M 453M 410M 767M 781M 5.4B 2.17B 27.45B 2.06B 2.02B 86.55B | EV / Sales 2027 * |
1.9x | EV / Sales 2028 * | 1.61x |
| Free-Float |
37.72% | Yield 2027 * |
-
| Yield 2028 * | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| 524164 | Delayed | |
NSE India S.E.
| IOLCP | Delayed |
Last Transcript: IOL Chemicals and Pharmaceuticals Limited
| 1 day | -3.84% | ||
| 1 week | +8.78% | ||
| 1 month | -14.21% | ||
| 3 months | +21.58% | ||
| 6 months | +88.69% | ||
| Current year | +116.11% |
| 1 week | 157.95 | 189.3 | |
| 1 month | 157.95 | 224 | |
| Current year | 67.14 | 224 | |
| 1 year | 67.14 | 224 | |
| 3 years | 57.51 | 224 | |
| 5 years | 54.44 | 224 | |
| 10 years | 8.4 | 224 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | 34 | - |
Pardeep Khanna
DFI | Director of Finance/CFO | - | - |
Abhay Raj Singh
CMP | Compliance Officer | - | 14/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Varinder Gupta
CHM | Chairman | 63 | 01/09/2007 |
Vikas Gupta
BRD | Director/Board Member | 34 | 29/05/2015 |
| Chairman | 73 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.84% | +8.78% | +91.95% | +111.10% | 549M | ||
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | ||
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | ||
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | ||
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | ||
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | ||
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | ||
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | ||
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | ||
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | ||
| Average | +1.49% | +6.19% | +51.12% | +87.22% | 426.25B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +100.44% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 27.42B 289M 259M 238M 216M 403M 411M 2.84B 1.14B 14.43B 1.08B 1.06B 45.49B | 32.4B 341M 306M 281M 255M 476M 485M 3.35B 1.35B 17.04B 1.28B 1.25B 53.75B |
| Net income | 2.2B 23.15M 20.73M 19.07M 17.28M 32.3M 32.9M 227M 91.29M 1.16B 86.88M 85.03M 3.65B | - |
| Net Debt | - | - |
Employees
3,095
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ₹177.75 | -3.84% | 119,149 |
| 29/10/26 | ₹184.85 | +2.35% | 160,897 |
| 28/10/26 | ₹180.60 | +0.89% | 158,324 |
| 27/10/26 | ₹179.00 | +6.58% | 113,903 |
| 26/10/26 | ₹167.95 | +2.78% | 96,364 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
177.75INR
Average target price
223.00INR
Spread / Average Target
+25.46%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 524164 Stock
Select your edition
All financial news and data tailored to specific country editions

















